SymBiosis Capital Management
Bentonville, Arkansassymbiosis.vc
Overview
SymBiosis Capital Management is a venture capital investment firm based in Bentonville, Arkansas. The firm invests solely in novel therapeutics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| R1 Therapeutics | Mar 2026 | Series A | Co-investor |
| Aeovian Pharmaceuticals | Dec 2025 | Series B | Co-investor |
| Sanegene Bio | Dec 2025 | Series B | Co-investor |
| Solve Therapeutics | Nov 2025 | Early Funding | Co-investor |
| Paradox Immunotherapeutics | Feb 2025 | Early Funding | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.